Long term impacts

Kawasaki Disease is an increasingly common vasculitis with risk of coronary artery aneurysms. The last UK survey was in 1990. Current epidemiology, treatment patterns and complication rates are unknown. The aim of this study, undertaken across the UK and Ireland, was to address this knowledge gap.

Every clinician needs a high index of suspicion. This paper contains new information to enhance it.

The first UK study to retrospectively review and characterise the angiographic prevalence of Kawasaki Disease

Patients with Kawasaki Disease exhibited a substantially higher risk for developing myopia according to research in Taiwan.

This review addresses gaps in the current knowledge of the disease and its optimal treatment, differences in the AHA and JCS guidelines, targets for future research and obstacles to transition of care from adolescence into adulthood.

This systematic review and meta-analysis demonstrates that adjunctive corticosteroid therapy was associated with a significantly lower rate of coronary artery complication compared with intravenous immunoglobulin therapy, particularly among high-risk patients.

This paper explores the acute dermatologic manifestations of Kawasaki Disease

Aberrant immune responses are considered to play key roles in KD initiation and breastfeeding can mature immune system in infants. We examined the association between breastfeeding and the development of KD.

This study indicates that sensorineural hearing loss in children with Kawasaki Disease might occur during treatment of the acute phase; this SNHL usually involves mild bilateral hearing loss and recovers naturally.

This study examined circulating endothelial cells (CECs) years after Kawasaki Disease